Immunovant financial statements

Name: Quantus Signal — KR/US technical signal dataset
License: https://www.quantus.kr/signal/terms

이뮤노반트NASDAQ:IMVT · Nasdaq · Healthcare

$33.62-0.09%

2026-10-02 close

Immunovant's published financial data is dated 2026-10-04. 2025 revenue was $0M. 2025 operating profit was −$438M.

Reported results

Quantus Signal · live data · not investment advice · Privacy Policy